AN2 Therapeutics, Inc. (ANTX:NASDAQ) closed at $4.55 on November 13, 2026, up 2.48% on the day. The stock trades 36.7% below its 52-week high of $7.19 and 355.0% above its 52-week low of $1.00. Over the past year, it gained 306.3%. AN2 Therapeutics, Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, ANTX closed higher on 115 days (46%). Its best day was March 9, 2026 (+84.21%) and its worst was October 13, 2026 (-16.28%). The stock moved 10% or more in a single session 12 times. It opened at least 5% above the previous day's high 1 time.
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.
Find more stocks like ANTX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.